Global Next Generation Sequencing Market 2012 - 2016
Albany, NewYork (PRWEB) October 19, 2013
Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market.
Complete report with TOC @ http://www.researchmoz.us/global-next-generation-sequencing-market-2012-2016-report.html.
Global Next Generation Sequencing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Next Generation Sequencing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc.
Browse all latest market research report @ http://www.researchmoz.us/latest-report.html.
The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics Corp., Axeq Technologies Inc., Beijing Genomics Institute, GeneDx, Fluidigm Corp., Foundation Medicine Inc., Good Start Genetics Inc., Helicos BioSciences Corp., Knome Inc., NABsys Inc., Oxford Nanopore Technologies Ltd., Pathogenica Inc., QIAGEN N.V, RainDance Technologies Inc., Sequenom Inc., Takara Bio Inc.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of these key vendors?
Visit all biotechnology market research reports @ http://www.researchmoz.us/biotechnology-market-reports-30.html.
1. Executive Summary
2. Scope of the Report
2.1 Market Overview
2.2 Product Offerings
3. Market Research Methodology
3.1 Market Research Process
3.2 Research Design
3.3 Research Methodology
4. List of Abbreviations
6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 Next Generation Sequencing Market in
Read all Technavio market research report @ http://www.researchmoz.us/publisher/technavio-73.html.
List of Exhibit
Exhibit 1: Market Research Methodology
Exhibit 2: Global Next Generation Sequencing Market Segmentation
Exhibit 3: Global Genomics Market Segmentation
Exhibit 4: Global Genomics Market Segmentation
Exhibit 5: Global Next Generation Sequencing Market 2012-2016 (US$ million)
Exhibit 6: Next Generation Sequencing Market in the US 2012-2016 (US$ million)
Exhibit 7: Next Generation Sequencing Market in Europe 2012-2016 (US$ million)
Exhibit 8: Next Generation Sequencing Market in Japan 2012-2016 (US$ million)
Exhibit 9: Global Next Generation Sequencing Market Segmentation by Application
Exhibit 10: Global Next Generation Sequencing Market Segmentation by Technology
Transcriptomics Technologies Market (http://www.researchmoz.us/transcriptomics-technologies-market-microarrays-pcr-gene-regulation-and-next-generation-sequencing-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html)
Transcriptomics refer to the structural and functional aspects of complete set of transcripts present in an individual or group of cells. The demand for transcriptomics research is increasing majorly due to consistent technological upgradations in several techniques (such as polymerase chain reaction (PCR), ribonucleic acid (RNA) sequencing and microarrays, etc.) employed for transcriptome analysis. The other notable factors include increased research in the field of “omics” technologies followed by heightened preference for personalized medicine which further propel transcriptomics market growth.
Opportunities in Human Embryonic Stem Cell Industry (http://www.researchmoz.us/opportunities-in-human-embryonic-stem-cell-hesc-products-trends-and-forecasts-to-2017-report.html)
Embryonic stem cells are stem cells derived from the inner cell mass of a blastocyst, which is a stage reached four to five days post-fertilization. They are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body. Human embryonic stem cells (hESCs) were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the University of Wisconsin-Madison. Another breakthrough followed at the University of Wisconsin-Madison in November 1998 when a group led by Dr. James Thomson developed a technique to isolate and grow hESCs derived from human blastocysts.
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948